Hepatitis Therapeutics Market Size, Share, And Trend Analysis By Disease Type (Hepatitis A, B, C) By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1. Methodology and Scope
                  1.1. Research Methodology
                  1.2. Research Scope & Assumptions
                  1.3. List of Data Sources
Chapter 2. Executive Summary
                  2.1. Market Snapshot
Chapter 3. Hepatitis Therapeutics Market Variables, Trends & Scope
                  3.1. Market Segmentation
                  3.2. Market Dynamics
                       3.2.1. Market driver analysis
                       3.2.2. Market restraint analysis
                  3.3. Key Opportunities Prioritized
                  3.4. Industry Analysis - Porter's
                  3.5. Hepatitis Therapeutics Market-SWOT Analysis, By Factor (political & legal, economic and technological), 2015
Chapter 4. Hepatitis Therapeutics Market: Disease Type Estimates & Trend Analysis
                  4.1. Hepatitis Therapeutics Market Share by Disease Type, 2015 & 2025 (USD Million)
                  4.2. Hepatitis A
                       4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
                  4.3. Hepatitis B
                       4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
                  4.4. Hepatitis C
                       4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
                  4.5. Others
                       4.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
Chapter 5. Hepatitis Therapeutics Market: Regional Outlook, By Disease Type
                  5.1. Hepatitis Therapeutics Market share by region, 2015 & 2025 (USD Million)
                  5.2. North America
                       5.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.2.2. The U.S.
                            5.2.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.2.3. Canada
                            5.2.3.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                  5.3. Europe
                       5.3.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.3.2. Germany
                            5.3.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.3.3. The U.K.
                            5.3.3.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                  5.4. Asia Pacific
                       5.4.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.4.2. China
                            5.4.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.4.3. Japan
                            5.4.3.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                  5.5. Latin America
                       5.5.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.5.2. Brazil
                            5.5.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.5.3. Mexico
                            5.5.3.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                  5.6. The Middle East & Africa
                       5.6.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
                       5.6.2. South Africa
                            5.6.2.1. Market estimates and forecast by disease type, 2014 - 2025 (USD Million)
Chapter 6. Competitive Landscape
                  6.1. Gilead Lifesciences
                       6.1.1. Company overview
                       6.1.2. Financial performance
                       6.1.3. Product benchmarking
                       6.1.4. Strategic initiatives
                  6.2. Bristol-Myers Squibb Co
                       6.2.1. Company overview
                       6.2.2. Financial performance
                       6.2.3. Product benchmarking
                       6.2.4. Strategic initiatives
                  6.3. Biocon
                       6.3.1. Company overview
                       6.3.2. Financial performance
                       6.3.3. Product benchmarking
                       6.3.4. Strategic initiatives
                  6.4. AbbVie
                       6.4.1. Company overview
                       6.4.2. Financial performance
                       6.4.3. Product benchmarking
                       6.4.4. Strategic initiatives
                  6.5. Merck & Co., Inc.,
                       6.5.1. Company overview
                       6.5.2. Financial performance
                       6.5.3. Product benchmarking
                       6.5.4. Strategic initiatives
                  6.6. Johnson & Johnson
                       6.6.1. Company overview
                       6.6.2. Financial performance
                       6.6.3. Product benchmarking
                       6.6.4. Strategic initiatives

List of Tables

TABLE 1 Hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 2 North America hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 3 U.S. hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 4 Canada hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 5 Europe hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 6 Germany hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 7 U.K. hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 8 Asia Pacific hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 9 China hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 10 Japan hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 11 Latin America hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 12 Brazil hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 13 Mexico hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 14 Middle East & Africa hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)
TABLE 15 South Africa hepatitis therapeutics market estimates and forecast by disease type, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market summary
FIG. 5 Market trends & outlook
FIG. 6 Market segmentation & scope
FIG. 7 Market driver relevance analysis (Current & future impact)
FIG. 8 Market restraint relevance analysis (Current & future impact)
FIG. 9 Key Opportunity Priorities
FIG. 10 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Hepatitis therapeutics market, Heat Map Analysis
FIG. 13 Hepatitis therapeutics market product outlook key takeaways
FIG. 14 Hepatitis therapeutics market: Disease type movement analysis
FIG. 15 Hepatitis A market, 2014 - 2025 (USD Million)
FIG. 16 Hepatitis B market, 2014 - 2025 (USD Million)
FIG. 17 Hepatitis C market, 2014 - 2025 (USD Million)
FIG. 18 Other hepatitis therapeutics market, 2014 - 2025 (USD Million)
FIG. 19 Regional outlook, 2015 & 2024
FIG. 20 North America hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 21 U.S. hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 22 Canada hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 23 Europe hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 24 Germany hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 25 U.K. hepatitis therapeutics market estimates and forecasts, 2014 - 2025 (USD Million)
FIG. 26 Asia Pacific hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 27 China hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 28 Japan hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 29 Latin America hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 30 Brazil hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 31 Mexico hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 32 MEA hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)
FIG. 33 South Africa hepatitis therapeutics market estimates and forecasts, 2013 - 2024 (USD Million)